Loading provider…
Loading provider…
Dermatology Physician in Houston, TX
NPI: 1003876285Primary Practice Location
Sagis, PLLC
4131 Directors Row, Houston, TX
Primary Employer
Alliance Pathology Consultants PA
HQ Phone
Get M.D. Howard's Phone NumberMobile
Get M.D. Howard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1988 - 2027
OK State Medical License
1988 - 1998

American Board of Dermatology
Dermatology

American Board of Dermatology
Dermatopathology
OU College of Medicine
medicine.ouhsc.edu
Fellowship • Dermatopathology
1991 - 1992
McGovern Medical School
med.uth.edu
Medical School
Until 1987
University of Oklahoma Health Sciences Center
Residency • Dermatology
1988 - 1991
University of Arkansas for Medical Sciences (UAMS) College of Medicine
Internship • Transitional Year
1987 - 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 1,843 | 3,497 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 469 | 758 |
| 3 | 17000Destruction of skin growth | 327 | 511 |
| 4 | 17003Destruction of 2-14 skin growths | 266 | 1,544 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 236 | 341 |
A case of indeterminate dendritic cell tumor presenting with leonine facies
Authors: Jonathan Curry, Madeleine Duvic, Carlos Torres Cabala, Doina Ivan
Journal: J Cutan Pathol
Publication Date: 2015-09-11
A case of indeterminate dendritic cell tumor presenting with leonine facies.
Authors: Chee Oh, Doina Ivan, Jonathan Curry, Rachel Ellis, Howard Gerber, Madeleine Duvic, Carlos Torres Cabala
Publication Date: 2014-10-14
Microreticular perineurioma: A new morphological subtype of a rare entity.
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Sanofi
Intervention / Treatment: DRUG: Dupilumab, DEVICE: Prefilled syringe, DEVICE: Auto-injector Device